Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine saliva versus plasma pharmacokinetic study in healthy men
NL-OMON35531Active, not recruiting
- Sponsor
- UCB
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of rotigotine in Parkinson's disease (PD) and restless legs syndrome (RLS), sponsored by UCB. Primary endpoints: Plasma and saliva rotigotine concentrations, Pharmacokinetic parameters and 1 more. Started Oct 2011; status: active, not recruiting.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)restless legs syndrome (RLS)
Beyond the preview
Go deeper on NL-OMON35531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35531.